# Tenon Medical, Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Tenon Medical, Inc.).

## Overview

Tenon Medical, Inc. is a U.S.-based medical device company focused on implant systems for sacroiliac joint and related orthopedic procedures. Its business centers on The Catamaran System and the SImmetry SI Joint Fusion System, which are sold to clinicians and used in surgical treatment of the pelvis and lower spine.

## Products & services

• The Catamaran System SI joint implant system
• SImmetry SI Joint Fusion System
• Implant components and instruments
• Catamaran Tray Sets
• Surgical support for orthopedic procedures

- **SI joint implant systems** (85%) — Implant systems used in sacroiliac joint fusion and related orthopedic procedures.
- **Surgical instruments and tray sets** (15%) — Reusable or semi-reusable instrument trays and related procedural tools used with the implant systems.

- The Catamaran System SI joint implant system
- SImmetry SI Joint Fusion System
- Implant components and instruments
- Catamaran Tray Sets
- Surgical support for orthopedic procedures

## Customers

Tenon sells primarily to clinicians who perform sacroiliac joint and orthopedic procedures, rather than to hospitals as a broad consumables supplier. Revenue depends on procedure volume, the number of implants used per patient, and purchasing activity by a limited number of physicians and independent sales representatives. The customer base is concentrated in specialty surgical practices and procedure centers that adopt the company’s implant systems for specific spine and pelvic indications.

- **Orthopedic and spine clinicians** (primary) — Buy implant systems for sacroiliac joint fusion procedures and choose products based on clinical preference and workflow.
- **Surgical practices and procedure centers** (primary) — Use the systems in recurring cases where implant kits, tray sets, and support materials are needed.
- **Independent sales representative network** (secondary) — Influences physician adoption and case conversion by supporting product education and case coverage.

- Orthopedic and spine clinicians performing SI joint procedures
- Physicians using the Catamaran System in surgical cases
- Clinics and practices that adopt new fusion implant systems
- Procedure volume drives purchases and repeat use
- Independent sales representatives influence physician adoption

## Geography

Tenon is headquartered in the United States and appears to generate substantially all revenue in the U.S. based on the disclosures provided. The company’s operating footprint is tied to U.S. clinicians, contract manufacturing, and domestic commercialization of its implant systems. Geography matters mainly through U.S. reimbursement, regulatory requirements, and the concentration of sales activity in a single market.

- Headquartered in the United States
- Revenue appears concentrated in the U.S. market
- Sales depend on domestic clinician adoption and reimbursement
- Contract manufacturing supports the product supply chain
- No country-level revenue disclosure was provided

## Strategy

Tenon’s strategy is to grow procedure volume and broaden adoption of its implant systems among clinicians treating sacroiliac joint disorders. It also relies on product development, commercial execution, and external financing to support operations while expanding its installed base and case activity. The company’s direction is shaped by the need to convert physician interest into recurring surgical use and to maintain supply through contract manufacturing.

- **Increase clinician adoption and case volume** (short-term) — Revenue is tied to procedures performed and implants used per patient.
- **Expand the product portfolio around SI joint fusion** (medium-term) — A broader implant offering can support more procedures and customer retention.
- **Secure funding for commercialization and R&D** (short-term) — The business requires capital to support sales, development, and working capital.

- Expand adoption of the Catamaran System and SImmetry system
- Increase case volume through clinician education and sales coverage
- Support commercialization with independent representatives
- Use contract manufacturing to scale product supply
- Raise external capital to fund operations and growth

## Risks

Tenon faces concentration risk because substantially all revenue comes from a limited number of clinicians and depends on procedure volume. The company also has financing and going-concern risk, since it has not generated positive operating cash flow and may need additional capital to continue operations. As a medical device business, it is also exposed to reimbursement changes, regulatory developments, competition, and manufacturing/supply-chain execution risk.

- **Customer concentration** [high] — Substantially all revenue comes from sales to a limited number of clinicians.
- **Going-concern and liquidity risk** [critical] — The company has not achieved positive cash flow and may need additional capital.
- **Reimbursement and adoption risk** [high] — Procedure demand can change with reimbursement, physician activity, and sales rep coverage.
- **Manufacturing and quality risk** [medium] — Products are produced by contract manufacturers, increasing reliance on third parties.

- Revenue concentration in a limited number of clinicians
- Procedure volume and reimbursement can swing quarterly sales
- Need for external financing creates dilution and covenant risk
- Regulatory changes can affect existing products and approvals
- Contract manufacturing creates supply and quality execution risk

## Accounting

Tenon’s revenue recognition is closely tied to point-in-time sales of implant systems and can fluctuate with case timing, discounts, rebates, and the number of implants used per patient. Investors should also watch inventory obsolescence, depreciation of tray sets, and stock-based compensation because these can materially affect reported margins and operating expenses in a small commercial-stage device company.

- **Revenue recognition on implant sales** — Quarter-to-quarter volatility in reported sales
- **Inventory obsolescence and scrap** — Gross margin and cost of goods sold
- **Tray set depreciation** — Product cost and margin presentation
- **Stock-based compensation** — Operating expenses and net loss

- Revenue varies with case timing, discounts, rebates, and implant usage
- Contract manufacturing affects cost of goods sold and gross margin
- Inventory obsolescence and scrap can move reported product costs
- Tray set depreciation affects cost allocation over time
- Stock-based compensation is a meaningful operating expense item

---

*Last updated: 2026-04-29T05:03:22.477563+00:00*